Dr. Temple contributed to a recent article on a stem cell clinical trial that has recently received the Food and Drug Administration's new Regenerative Medicine Advanced Therapy (RMAT) designation. Read more about how this new designation will help to promote the advancement of legitimate stem …
Dr. Messer hosts webinar for “The Scientist”
Dr. Anne Messer was one of two experts chosen to present a webinar for The Scientist (March 8, 2018.) Antibodies are the fastest growing class of synthetic therapeutics, and Dr. Messer's presentation covered their development and use as therapeutics and markers for neurodegenerative diseases. She …
Support NSCI on November 28th, #GivingTuesday
Celebrate your kindness on #GivingTuesday. On #GivingTuesday, a national day of donation, consider a gift to the Neural Stem Cell Institute. Your gift gets us closer to therapies for incurable diseases of the central nervous system including Macular Degeneration, Alzheimer's, Parkinson's, Spinal …
Unique Surgical Technique Published in Video Journal
NSCI Researchers Create Unique Surgical Technique to Aide Research in Quest for Retinal Disease Therapeutic RENSSELAER N.Y., August 30, 2017 - Age-related macular degeneration (AMD), a progressive degenerative disease of the retina, is the leading cause of blindness in the elderly. Patients with …
Students from Averill Park High School visit NSCI labs
A Molecular Biology class from Averill Park High School visited the labs at NSCI. These twenty-one 9th and 10th graders were able to learn from researchers, explore the lab and experience a range of scientific wet lab activities first hand. Leading the workshop, NSCI’s Dr. Thomas Kiehl …